News

Published on 21 Mar 2024 on Simply Wall St. via Yahoo Finance

Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend...


Article preview image

Exelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decided to pay attention to the company's fundamentals which don't appear to give a clear sign about the company's financial health. Particularly, we will be paying attention to Exelixis' ROE today.

Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. Simply put, it is used to assess the profitability of a company in relation to its equity capital.

View our latest analysis for Exelixis

NASDAQ.EXEL price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Institutional investors in Exelixis, Inc. (NASDAQ:EXEL) lost 3.8% last week but have reaped the...

Key Insights Significantly high institutional ownership implies Exelixis' stock price is sensitiv...

Simply Wall St. via Yahoo Finance 17 Apr 2024

Exelixis stock slips as Barclays downgrades (NASDAQ:EXEL)

Exelixis (EXEL) stock traded lower after Barclays downgraded the cancer drugmaker due to a lack o...

Seeking Alpha 11 Apr 2024

Top Research Reports for SAP, Verizon Communications & Lowe's

Monday, April 8, 2024The Zacks Research Daily presents the best research output of our analyst te...

Zacks via Yahoo Finance 8 Apr 2024

Exelixis, Inc.'s (NASDAQ:EXEL) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend...

Exelixis' (NASDAQ:EXEL) stock is up by a considerable 16% over the past month. However, we decide...

Simply Wall St. via Yahoo Finance 21 Mar 2024

The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and...

For Immediate Release Chicago, IL – March 11, 2024 – Zacks.com announces the list of stocks featu...

Zacks via Yahoo Finance 11 Mar 2024

Top Stock Reports for Chevron, Verizon & Eaton

Friday, March 8, 2024The Zacks Research Daily presents the best research output of our analyst te...

Zacks via Yahoo Finance 8 Mar 2024

10 Biotech Stocks with Huge Potential

In this article, we will take a look at the 10 biotech stocks with huge potential. To skip our an...

Insider Monkey via Yahoo Finance 8 Mar 2024

10 Mid-Cap Stocks with Insider Purchases

In this article, we will take a detailed look at the 10 Mid-Cap Stocks with Insider Purchases. Fo...

Insider Monkey via Yahoo Finance 7 Mar 2024

3 Cutting-Edge Biotech Stocks Sitting on the Brink of Success

Biotech stocks have always been high-risk and high-reward, with the futures and fortunes of compa...

InvestorPlace via Yahoo Finance 7 Mar 2024

Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments

Exelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...

GuruFocus.com via Yahoo Finance 27 Feb 2024